We sold Novo Nordisk out of the portfolio due to two concerns that made us question the company’s ability to deliver ...

Third-quarter results will be the first for Mike Doustdar who was tasked in August with turning around the Danish company's ...

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally developed to treat diabetes, could help trim their ...